Fifth Lane Capital, LP Adagene Inc. Transaction History
Fifth Lane Capital, LP
- $39.4 Million
- Q2 2025
A detailed history of Fifth Lane Capital, LP transactions in Adagene Inc. stock. As of the latest transaction made, Fifth Lane Capital, LP holds 27,500 shares of ADAG stock, worth $52,525. This represents 0.13% of its overall portfolio holdings.
Number of Shares
27,500
Previous 27,500
-0.0%
Holding current value
$52,525
Previous $41,000
29.27%
% of portfolio
0.13%
Previous 0.22%
Shares
1 transactions
Others Institutions Holding ADAG
# of Institutions
13Shares Held
9.65MCall Options Held
0Put Options Held
0-
Wu Xi App Tec Co., Ltd. Shanghai, F43.98MShares$7.61 Million46.44% of portfolio
-
General Atlantic LLC New York, NY3.83MShares$7.31 Million0.26% of portfolio
-
Sc China Holding LTD N/A, K31.34MShares$2.57 Million0.16% of portfolio
-
Mill Creek Capital Advisors, LLC Conshohocken, PA200KShares$381,2550.01% of portfolio
-
Kamunting Street Capital Management, L.P. Miami Beach, FL126KShares$240,7210.22% of portfolio
About Adagene Inc.
- Ticker ADAG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,423,200
- Market Cap $82.9M
- Description
- Adagene Inc., a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers. The company's product candidates include ADG106, a human ligand-blocking agonistic anti-CD137 monoclonal antibodies (mAbs) that is in Phase 1b/2 clinical trials for the treatment advanced solid ...